Passion for Swiss equities

zMonthly Dividend Fund 02/2024

Monthly report February 2024 of the zCapital Swiss Dividend Fund (class A)

In February, the fund recorded an increase of 1.1% (SPI +0.6%). During the month we bought additional shares in Nestlé, Valiant, Hiag Immobilien, Roche and VAT Group. On the other hand, we trimmed our positions in Accelleron, Swiss Re, Swiss Life, Novartis, SGS and Inficon.

Stock markets outside Europe set the tone for the month. Strong US employment data and optimism about the growth of artificial intelligence drove some indices in the USA and Japan to new record highs. Nvidia's sales and the very optimistic outlook led to a broad-based rally.

Valuations of stocks in artificial intelligence, semiconductors and anti-obesity drugs have risen massively on the back of growth fantasies, while in the traditional sectors there are more and more cheap stocks to be found. As long as market participants do not see any signs of recovery in the cyclical sectors, valuation differentials are unlikely to change. European markets will continue to be dominated by the reporting season.

This website uses cookies

We use cookies, as well. They facilitate the use of the website. Learn more about